NCT06392217View on ClinicalTrials.gov

clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions

Breast CancerBone Metastases

Trial Locations (1)

200032

RECRUITING

Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER